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Background: Type 2 diabetes is an increasingly common chronic condition whose prognosis can be improved by
patient involvement and self-management. Patient involvement can be fostered by web-based Interactive Health
Communication Applications (IHCAs) combining health information with decision support, social support and/or
behaviour change support. They reach great numbers of patients at low cost and provide high-quality information
and support at the time, place and learning speed patients prefer. Still, online tools often suffer from high attrition.
Tailoring content and tone of IHCAs to the individual patient´s needs might improve their effectiveness. This study
aims to test the effectiveness and usage of a tailored IHCA combining health information with decision support
and behaviour change support for patients with type 2 diabetes.
Methods/design: The effectiveness and usage of the tailored IHCA will be tested against a standard website with
identical content in a single-blinded randomized trial with a parallel design. The content covers information on
type 2 diabetes, its complications and sequelae, and its treatment options including health behaviour. In the
intervention group the content is delivered in dialogue form, tailored to relevant patient characteristics (health
literacy, attitudes towards self-care, and barriers to insulin treatment). In the control group the different sections are
presented in a content tree, without any tailoring. Participants are blinded to group assignment. Eligibility criteria
are age ≥ 18 years, self-reported type 2 diabetes, and Internet access. The study aims to include 414 participants in
order to detect the expected small effect (Cohen’s d=0.2), with measurements at baseline, directly after the first
visit, and at 3-month follow-up. The primary hypothesis is that the tailored IHCA has larger effects on diabetes
knowledge and patient empowerment (primary outcomes) than the standard website. Secondary outcomes are
website usage as well as decisional conflict and preparation for decision making. All measurements are online
self-report questionnaires.
Discussion: IHCAs are a promising way to foster diabetes knowledge and self-management competencies. The
present trial tries to increase the knowledge on how to develop more effective IHCAs for patients with type 2
diabetes.
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Diabetes and its secondary diseases are a leading cause
of morbidity and mortality in many countries. The num-
ber of people living with diabetes more than doubled
during the last three decades [1]. Projections expect the
prevalence to rise from 2.8% in 2000 to 4.4% in 2030 [2].
Type 2 diabetes accounts for 90 to 95% of diabetes cases
[3]. Patients, practitioners, scientists and politicians have
called for more active patient involvement in the making
of medical decisions as well as in the management of
diabetes. Patient involvement has been shown to reduce
fasting blood glucose levels, glycated hemoglobin levels,
and the need for diabetes medication [4]. Two main
aspects of patient involvement are self-management
and shared decision-making (SDM). Both for shared
decision-making and for self-management patients need
to be informed about their disease, its course, and the
treatment options at hand, including their advantages
and disadvantages. However, due to limited resources in
health care, large numbers of patients still do not have
access to feasible diabetes education [5,6].
In times of rapidly growing Internet penetration, the
web holds the opportunity to deliver health information
and support to large numbers of participants on com-
paratively low cost and at the time, place and learning
speed the individual users prefer. Trials of systematically
and thoroughly developed online health interventions
show small but consistent effects on clinical outcomes
[7-9] even in older populations that are generally
thought to be less inclined to use the web [10]. Murray
et al. [11] reviewed the effects of a format that combines
health information with at least one other type of sup-
port, e.g., social support, decision support, or behaviour
change support (= “Interactive Health Communication
Applications”, IHCAs) [11]. They found that IHCAs can
have positive effects on knowledge, social support, clin-
ical, and behavioural outcomes.
Still, the effectiveness of those online applications is
limited by high attrition rates [12,13], and few users visit
a health intervention website more than once [14,15].
Since the effect of online interventions increases with
dose (longer stays, repeated website visits, total contact
hours) [15,16], effectiveness is maximized if patients
work intensively with the information offered [17,18]
and return for repeated visits [19,20]. Individualization
and personalization of information as well as an inter-
active presentation have been found to effectively in-
crease exposure to and effectiveness of interventions
[21,22]. These three strategies can be subsumed under
the concept of tailoring [23].
Aims of the trial
This trial tests an IHCA presenting diabetes information,
self-management education and decision support in adialogue-based, tailored format against a website
presenting the same information in a content tree with-
out dialogue or tailoring. The primary hypothesis is that
the interactive and individualized delivery format has
larger effects on diabetes knowledge and patient em-
powerment than the standard website. Exploratory re-
search questions are if usage is higher for the interactive
and individualized delivery format and whether users fa-
cing a health decision experience less decisional conflict
and feel better prepared for the consultation after using




We chose a single-blinded two-armed randomised con-
trolled trial (RCT) with a parallel design. We aim to in-
clude N=414 participants. Measurements are scheduled
immediately before the first use of the system, immedi-
ately after and at three month follow-up. Diabetes know-
ledge (primary outcome), decisional conflict, and
preparation for decision making (secondary outcomes)
are assessed immediately after the first visit. Patient em-
powerment (secondary outcome) is assessed three
months after the first visit (see figure 1).
Study procedures
After providing an informed consent and completing the
pre-assessment (eligibility criteria, demographic data,
time since diagnosis, treatment) the participants are ran-
domly assigned to the tailored IHCA or the standard
website with the content tree. In the intervention group,
the questions used for tailoring are presented during the
dialogue. Participants assigned to the control condition
where no tailoring takes place fill in these questionnaires
immediately before visiting the website in order to con-
trol for baseline disparities between intervention and
control group. Immediately after their first visit to the
IHCA or the standard website all participants are asked
to fill in the post-assessment.
All participants receive an e-mail three months after
their first visit asking them to fill in the follow-up online
questionnaire. Because non-monetary incentives have
been shown to reduce attrition in online trials [24,25],
participants who have answered all questionnaires re-
ceive a 10 € amazon gift voucher. The voucher code is
sent to them by e-mail at the end of the study. Figure 1
gives an overview of the study procedures.
Participants are free to use the intervention as often and
as long as they wish, also between the post and
follow-up assessment. Information on frequency and dur-
ation of usage is gathered via server registrations. Usage
data, data from the self-assessment questionnaires, and









pre-assessment (t1)                        
- demographic data
- diabetes knowledge
- attitudes toward self-care




- attitudes toward self-care
- barriers to insulin treatment
standard website
post–assessment (t2) immediately after first visit
- diabetes knowledge (primary outcome)
- decisional conflict (secondary outcome)
- preparation for decision making (secondary outcome
assessment of usage (server registration)
follow-up-assessment (t3) after 3 months




Figure 1 Study procedures.
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personal data will be deleted. If a participant withdraws
his or her informed consent to study participation his or
her data shall be erased immediately. All data will be
erased five years after the end of the study. The study was
approved by the Hamburg Medical Chamber ethics
committee.
Treatment allocation
The informed consent informs participants that they will
be randomly assigned to one of two presentation
formats holding the same content. The two formats are
not further elucidated so participants do not know
whether they are in the intervention or control group.
Randomisation is performed by computer.
Recruitment
In Germany, health care for chronically ill patients is
organized in different sectors, mainly in acute-careclinics and rehabilitation centres for in-patient care, and
primary care and diabetology practices for out-patient
care. Treatment in acute-care clinics, in primary care
practices, and in diabetology practices is funded by
health insurance while rehabilitation in rehabilitation
centres is usually funded by pension funds. Study aim is
to include patients from all sectors. Recruitment takes
place via support from different health insurance com-
panies, pension funds, primary care practices and
diabetology practices, hospitals and rehabilitation
centres, and self-help groups. The study is advertised in
various media such as newspapers, magazines, patient
websites, and flyers. Information on the study is available
on the study website www.entscheidungshilfe.info.
Study Population
Eligibility criteria are age ≥ 18 years, access to the Inter-
net, and a self-reported diagnosis of type 2 diabetes.
According to the American Diabetes Association [3,26],
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glucose of ≥ 126 mg/dl or a non-fasting plasma glucose
of ≥ 200 mg/dl or a plasma glucose of ≥ 200 mg/dl two
hours after oral intake of 75g glucose (oral Glucose
Tolerance Test, oGTT) is measured. Supposing that
most patients cannot give these exact numbers and that
self-reported diagnoses are a valid criterion [27], we
decided to rely on self-reported diagnosis of type 2 dia-
betes as inclusion criterion.
Description of the intervention and control condition
The content of both the tailored IHCA and the standard
website covers basic information on diabetes (pathophysi-
ology, epidemiology, subtypes, symptoms) and its sequelae
(neuropathy, nephropathy, retinopathy, heart and vessel
problems, sexual dysfunction, and depression), informa-
tion on health behaviour and lifestyle changes, and treat-
ment options (see section Chapters and sections). The
look of the website (colours, typing, figures and pictures)
is identical in both conditions. After registration, each par-
ticipant receives a password via e-mail with which he/she
can log into the system as often as he/she wishes.
Chapters and sections
1. Introduction: What is this website?
1.1. Where does the information on this site come
from?
1.1.1. What are treatment guidelines?
1.1.2. What are disease management
programmes?
2. Basics
2.1. Different diabetes types2.1.1. Type 1
2.1.2. Type 2
2.1.3. Other types of diabetes2.2. How do I know I have type 2 diabetes?2.2.1. The most important signs
2.2.2. Other signs2.3. What causes type 2 diabetes?2.3.1. What causes insulin resistance?
2.3.2. Risk factors2.4. How many people live with type 2 diabetes?
2.4.1. Diabetes is on the rise2.5. How is type 2 diabetes diagnosed?
2.5.1. Fasting plasma glucose
2.5.2. Oral glucose tolerance test (oGTT)
2.5.3. Measurement units for blood sugar
2.5.4. HbA1c
2.5.5. Urine analysis2.6. Diabetes ABCs
2.6.1. „A“ is for HbA1c2.6.2. “B” is for blood pressure
2.6.3. „C“ is for cholesterol2.7. Blood sugar control2.7.1. What is it good for?
2.7.2. How to do it2.7.2.1. At the doctors´ practice
2.7.2.2. At home3. How is type 2 diabetes treated?
3.1. What are the goals of diabetes treatment?
3.2. What can you do to treat your diabetes?3.2.1. How do I keep a healthy diet?
3.2.2. Why is exercise important?
3.2.3. Why is smoking so bad if you have
diabetes?
3.3. When should you consider taking pills?3.3.1. Pills to treat type 2 diabetes




3.3.5. Glinides (repaglinide, nateglinide)
3.3.6. Glitazone
3.3.7. α-glucosidase inhibitor (AGI)
3.3.8. Dipeptidyl peptidase-4 inhibitor
3.3.9. Exenatide, liraglutide3.4. Insulin treatment
3.4.1. Human insulin and insulin analogues
3.4.2. When is insulin treatment initiated?
3.4.3. Hopes and fears when starting insulin
treatment
3.4.4. How is insulin administered?
3.4.5. Different types of insulin and their effects
3.4.6. How does insulin act in the body?
3.4.7. Insulins with different durations of action
3.4.8. Insulin treatment and blood sugar control
3.4.9. Combining pills and insulin3.5. Summary and overview of the treatment options
4. Acute complications and sequelae
4.1. Which acute complications can occur?4.1.1. Low blood sugar
4.1.2. High blood sugar4.2. Which sequelae can occur?







4.2.8. Depression5. Additional information and literature
5.1. Associations and self-help
5.2. Web sites







In the intervention the delivery format is a dialogue-
based, tunnelled design tailoring the content and tone of
the dialogue to relevant patient characteristics. A tun-
nelled design where the user is guided through the con-
tent was found to increase website use and knowledge
gained from a website more than a design with more
user control [28]. Still, it might also annoy the user and
evoke resistance [29]. Consequently we decided to give
the user some control over the path he/she takes
through the dialogue. At the end of each text passage
the user chooses one of at least three reply options and
receives a tailored answer. The answers mirror what the
user has said, convey esteem and empathy and build an
individualized bridge to the next content block.
Tailoring is performed on the following patient
characteristics: health literacy, attitudes towards self-care,
and, if insulin treatment is a relevant topic, psychological
barriers to it. The questionnaires that assess patient
characteristics are presented during the dialogue: In the
beginning of the respective section (e.g. diabetic foot),
the participant is asked about his or her knowledge or atti-
tude toward the topic. The following section is then modi-
fied according to his/her answer. Figure 2 shows a
dialogue window.
The user´s attitudes towards self-care are assessed
with items that we adapted from the Summary of Dia-
betes Self-care Activities Measure (SDSCA) [30] to
match the respective content section (see Table 1). The
question is always how important a certain self-care ac-
tivity or advice is for the individual user. Every item has
three reply options: “important or very important”, “aTable 1 Example of self-care tailoring
Item People with diabetes are advised to regularly check their feet and
importance they attach to “good advice“ of this kind. How import
Reply
options
not important a little important
Tailored
answer
OK, so this recommendation is not important
for you. Maybe you are very aware of the
inconvenience of daily foot care. You are
right there; it takes some effort in the
beginning. At the same time it helps a lot to
prevent diabetic foot syndrome. A diabetic
foot can be painful and can lead to
amputation. There is a great benefit for the
comparatively small effort of taking care of
your feet. For many people the first step is
the hardest. Once you get used to it, the
effort does not seem so great anymore.
OK, so this recomm
important for you.
the inconvenience
same time it helps
foot syndrome. A d
and can lead to am
benefit for the com
taking care of your
first step is the har
to it, the effort doe
anymore.little important”, and “not important”. The goal and
techniques are inspired by Motivational Interviewing
[31]. Motivational interviewing is a counseling method
for addressing ambivalence about change.
For example, if a user attaches great importance to the
self-care behavior in question, this is reinforced, positive
consequences of the self-care behavior are stressed, and/
or ideas are provided on how to keep up motivation. If a
user finds the self-care behavior in question “a little im-
portant”, understanding for the users´ ambivalence is
uttered, and the importance the user attaches to the self-
care behavior – little as it might be – is stressed and
reinforced. Finally, if a user rates the self-care behavior
as not important, the autonomy expressed in this answer
is respected in order not to elicit resistance.
Control condition
On the standard website, the content is not tailored and
is not presented in a dialogue format. In contrast to the
tailored, interactive version, it is not tunnelled; there is
no guidance through the content. On the right of each
page a content tree displays a menu of all content
sections that the participant can click on to get to the
content of interest (see Figure 3).
Potential risk for participants
Contraindications or side effects of IHCAs are not
known.
Intervention development and trial design
The development process was user-oriented, evidence-
based and peer reviewed. In order to find out which
topics are relevant to patients with type 2 diabetes, we
performed a needs assessment with two steps: First,
semi-structured interviews with seven physicians (all
internists, 1 working as a general practitioner, 2
specialized in diabetology) and ten patients with type 2
diabetes were conducted. In the second step, a self-the inside of their shoes. People differ a lot with respect to the
ant is this advice for you personally?
important or very important
endation is a little
Maybe you are aware of
of daily foot care. At the
a lot to prevent diabetic
iabetic foot can be painful
putation. There is a great
paratively small effort of
feet. For many people the
dest. Once you get used
s not seem so great
You are right, this recommendation is really
important. Looking after your feet can be
inconvenient but helps a lot to prevent
diabetic foot syndrome. A diabetic foot can
be painful and can lead to amputation.
There is a great benefit for the
comparatively small effort of taking care of
your feet.
Figure 2 Dialogue window.
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main results of the interviews, and it was administered
to a new and larger patient sample (N=178). The needs
assessment will be described in more detail elsewhere. In
order to ensure that information is evidence-based treat-
ment guidelines were used as primary sources. Based on
review articles [32,33], expert advice and up-to-dateness,
the British [34] and the American [26] guidelines were
chosen. Throughout the development, the content was
revised by an interdisciplinary advisory committee in an
iterative process. The development will be described in
more detail elsewhere.Outcome assessment
The primary outcomes are diabetes knowledge (assessed
immediately after the first visit) and patient empowerment
(assessed at three month follow-up). Diabetes knowledge is
assessed with 16 multiple-choice questions we developed
according to the IHCA´s content. Patient empowerment is
measured with the Health Education Impact Questionnaire
(HeiQ) [35,36]. The HeiQ includes 42 items and eight
dimensions: Positive and Active Engagement in Life, Health
Directed Behavior, Skill and Technique Acquisition, Con-
structive Attitudes and Approaches, Self-Monitoring and
Insight, Health Service Navigation, Social Integration and
Figure 3 Control window.
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[37] translated the questionnaire into German and
evaluated its psychometric properties (Raykov’s Composite
Reliability Coefficient, factorial and concurrent validity).
They were able to replicate the structure of the eight scales
and found the questionnaire to be a reliable and valid
measure. We removed Social Integration and Support from
our testing battery since we did not expect an effect of our
IHCA on that dimension.
Secondary outcomes are decisional conflict and prep-
aration for decision making. Decisional conflict is
assessed with the Decisional Conflict Scale (DCS) by O´
Connor [38]. This questionnaire measures personal
perceptions of uncertainty in choosing options, modifi-
able factors contributing to uncertainty such as feeling
uninformed, unclear about personal values and unsup-
ported in decision making, and effective decision making
such as feeling the choice is informed, values-based,likely to be implemented, and expressing satisfaction
with the choice. Reliability is good with a Cronbach´s α
between 0.78 and 0.92 [38]. Discriminant validity is
acceptable.
Preparation for decision making is measured with
the Preparation for Decision Making Scale (PDMS)
[39]. This 11 item scale assesses a patient´s or partici-
pant´s perception of how useful a decision aid or
decision support intervention was in preparing him or
her to communicate with his or her practitioner in
making a health decision. Reliability is very good ran-
ging from α=.92 to α=.94. Both questionnaires are
offered only to those participants who have indicated
that they are facing a health decision concerning their
type 2 diabetes. In order to avoid missing data, all
questionnaires include validation checks that alert
participants when their answers are implausible or
items are skipped.
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T-tests for independent samples will be performed
to test the hypotheses. Due to randomization and the
supposed structural equality of the groups we do not ex-
pect confounding factors. If we detect baseline disparities
between the control and intervention group they will be
included in an analysis of covariance (ANCOVA) as
confounding variables. Following the intention-to-treat ap-
proach we will include all randomized participants in the
analyses in order to avoid biases such as non-random attri-
tion of participants. Additionally we will perform a sensitiv-
ity analysis following the per-protocol approach including
only participants that have filled in all the questionnaires.
For all analyses α ≤ 0.05 will be the critical value for statis-
tical significance. We expect only small sample sizes with
respect to the exploratory research questions because only
a fraction of the participants will be facing a health decision
and will therefore be asked to fill in the DCS and PDMS.
For all parameters 95% confidence intervals will be defined
so we will be able to appraise the exactitude of testing.
Power calculation
On the basis of the Cochrane review by Murray et al.
[11] we expect a small effect on the primary outcomes
(Cohen’s d=0.2). To detect a small effect with an α of
0.05 and a power of 0.80 (one-tailed t-test), a sample size
of N=310 (155 per group) is required. Expecting a rate
of dropout 20% between registration and follow-up (3
months), we aim at including a sample of N=414 at
baseline.
Discussion
In an on-going RCT, we are testing a web-based, tailored,
dialogue-based information system that contains informa-
tion on type 2 diabetes and its sequelae, health behaviour,
and treatment options, against a standard website providing
identical information without dialogue structure, tailoring
or interactive elements. Both websites were thoroughly
developed based on a needs assessment and two evidence-
based guidelines, and reviewed by an interdisciplinary ad-
visory committee. The primary outcomes of the trial are
diabetes knowledge and patient empowerment. Secondary
outcomes are decisional conflict, preparation for decision
making, and website usage. The present study is the first
trial on a German language IHCA on type 2 diabetes.
There are some limitations to the work presented. The
most obvious limitation is that only people with Internet
access can be included in the study. 73% of the German
general population use the Internet [40], but of the
population over 50 years of age, 47% are online. Since
the prevalence of type 2 diabetes increases strongly with
age [41] we run the risk of excluding a part of our target
group. This is a limitation both with respect to imple-
mentation and reach, and as a source of selection bias.There are some disadvantages of online questionnaires,
namely the relatively high nonresponse rates and concerns
regarding data quality [42,43]. With regard to the quality of
the data obtained online, there are indications that the psy-
chometric properties are equivalent with data obtained
from paper pencil questionnaires or even better [44,45].
Quality can be improved by validation checks that alert
participants when their answers are implausible or items
are skipped [44]. Furthermore, online assessments seem to
be less prone to social desirability [46]. With respect to
non-responders we try to reduce attrition by keeping the
questionnaires as short as possible, making the intervention
itself attractive, and offering an incentive for answering all
questionnaires. Another limitation concerning our mea-
surements is that only some of them are standardized
(DCS, PDMS, BIT) while others are adapted (attitudes to-
ward self-care) or developed (diabetes knowledge) for our
purposes. None of the measurements have been adapted
for online use which puts their comparability to results
obtained from paper pencil tests into question [47].
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